Diagnosing and treating asymptomatic tuberculosis infection

Canadian Family Physician

Volumn 45, Issue OCT., 1999, Pages 2397-2404

  Wang, Cheng Tao ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRIDOXINE; RIFAMPICIN;

ADULT; CHILD; CLINICAL ARTICLE; FEMALE; HEPATITIS; HIGH RISK PATIENT; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL NEUROPATHY; PROPHYLAXIS; REVIEW; SCREENING; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTIBIOTIC PROPHYLAXIS; CANADA; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRACTICE GUIDELINES; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 0032734945     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989;38:1-21.
2. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 1992;146:1623-33.
3. Brancker A Tuberculosis in Canada 1989. Health Rep 1991;3:92-7.
4. Tuberculosis Committee, Canadian Thoracic Society. Canadian tuberculosis standards. 4th ed. Ottawa, Ont: Canadian Lung Association; 1996.
5. Canadian Centre for Health Information. Tuberculosis statistics. Ottawa, Ont: Statistics Canada; 1992;4(2 Suppl 10):5s-6s.